Lipidomics and Cardiac MRI in Dilated Cardiomyopathy
Author Information
Author(s): Marko Sysi-Aho, Juha Koikkalainen, Tuulikki Seppänen-Laakso, Maija Kaartinen, Johanna Kuusisto, Keijo Peuhkurinen, Satu Kärkkäinen, Margareta Antila, Kirsi Lauerma, Eeva Reissell, Raija Jurkko, Jyrki Lötjönen, Tiina Heliö, Matej Orešič
Primary Institution: VTT Technical Research Centre of Finland
Hypothesis
Can serum lipid profiles help identify subjects at risk of developing dilated cardiomyopathy?
Conclusion
The study found that LMNA mutation carriers have a distinct serum lipidomic profile that may precede the development of dilated cardiomyopathy.
Supporting Evidence
- LMNA mutation carriers showed significant differences in serum lipid profiles compared to healthy controls.
- Specific lipid changes were associated with cardiac shape and volume changes as measured by MRI.
- Odd-chain triglycerides were found to be diminished in both LMNA carriers and DCM patients.
Takeaway
This study looked at blood fats in people at risk for heart problems and found that certain fats can help predict heart issues before they happen.
Methodology
The study used Ultra Performance Liquid Chromatography coupled to mass spectrometry to analyze serum lipid profiles and cardiac MRI to assess heart function.
Potential Biases
The study may be biased due to the small number of participants and the specific population studied (Finnish LMNA mutation carriers).
Limitations
The study had a small sample size of LMNA mutation carriers, which may limit the generalizability of the findings.
Participant Demographics
The study included 11 LMNA mutation carriers and 11 matched healthy controls, with a mix of genders and ages ranging from 33 to 56 years.
Statistical Information
P-Value
0.0011
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website